What is the healthcare utilisation and out-of-pocket expenditure associated with osteoarthritis? A cross-sectional study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
09 03 2022
Historique:
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 28 4 2022
Statut: epublish

Résumé

To examine the use and out-of-pocket expenses resulting from consultations, products and practices across conventional, self-care, and complementary medicine (CM) treatments for osteoarthritis (OA) among Australian women. A cross-sectional survey of 800 women from the 45 and Up Study who had reported a clinical diagnosis of OA. Women's use of conventional, CM and self-prescribed treatments for OA and the associated out-of-pocket cost. Completed questionnaires were returned by 403 women (50.4%). Their average time since the first diagnosis of OA was 15.4 years, and self-rated severity of OA was 5.1 (out of 10) over the past 12 months. During the previous year, 67.0% of the women consulted a doctor, 39.2% consulted an allied health practitioner and 34.7% consulted a CM practitioner for their OA. Some women (19%) consulted with practitioner(s) from all three practitioner groups, 27% consulted with practitioner(s) from two of the three practitioner groups, while 6% consulted with a CM practitioner only. Women with a greater time since diagnosis had more consultations, as did women who rated their OA as more severe. Women's average combined out-of-pocket expenditure for OA-related healthcare consultations, prescription medications, products, and practices was $673 per annum. Extrapolated to all Australian women with OA, aged 50 years and over, the total out-of-pocket expenditure for this condition is estimated to be $873 million per annum. Australian women with OA use a range of conventional and CM consultations, self-care, products and practices to manage their condition, incurring significant out-of-pocket expenses. Given the high individual and societal burden of OA, there is a need for further research into the concurrent use of different healthcare resources with a view to providing safe, cost-effective management of OA across the healthcare system and the wider community.

Identifiants

pubmed: 35264358
pii: bmjopen-2021-055468
doi: 10.1136/bmjopen-2021-055468
pmc: PMC8915347
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e055468

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Clin Diagn Res. 2016 Feb;10(2):JE01-6
pubmed: 27042482
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Ann Phys Rehabil Med. 2016 Jun;59(3):134-138
pubmed: 26904959
Osteoarthritis Cartilage. 1998 Mar;6(2):87-93
pubmed: 9692063
Arch Osteoporos. 2021 Oct 4;16(1):148
pubmed: 34606032
Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74
pubmed: 22563589
BMC Complement Altern Med. 2014 Aug 23;14:312
pubmed: 25151529
Am Fam Physician. 2000 Mar 15;61(6):1795-804
pubmed: 10750883
Evid Based Complement Alternat Med. 2016;2016:6016532
pubmed: 27777597
Altern Ther Health Med. 2012 May-Jun;18(3):25-32
pubmed: 22875559
Evid Based Complement Alternat Med. 2016;2016:1813979
pubmed: 27635148
Osteoarthritis Cartilage. 2014 Mar;22(3):363-88
pubmed: 24462672
Osteoarthritis Cartilage. 2008 Feb;16(2):137-62
pubmed: 18279766
Int J Epidemiol. 2008 Oct;37(5):941-7
pubmed: 17881411
Osteoarthritis Cartilage. 2017 Jul;25(7):1010-1025
pubmed: 28232144
PLoS One. 2013 Dec 20;8(12):e83559
pubmed: 24376716
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Rheumatology (Oxford). 2020 Sep 1;59(9):2368-2373
pubmed: 31889197
Rheumatology (Oxford). 2012 Dec;51(12):2224-33
pubmed: 22923762
Osteoarthritis Cartilage. 2005 Sep;13(9):769-81
pubmed: 15978850
BMC Musculoskelet Disord. 2016 Sep 17;17(1):393
pubmed: 27639556
Evid Based Complement Alternat Med. 2016;2016:3485875
pubmed: 27818699
Osteoarthritis Cartilage. 2012 Jan;20(1):22-8
pubmed: 22033041
Int J Clin Pract. 2021 Mar;75(3):e13821
pubmed: 33159830

Auteurs

David Sibbritt (D)

Faculty of Public Health, University of Technology Sydney Faculty of Health, Sydney, New South Wales, Australia.

Tobias Sundberg (T)

Musculoskeletal and Sports Injury Epidemiology Center, Karolinska Institute, Stockholm, Sweden.

Lesley Ward (L)

Faculty of Public Health, University of Technology Sydney Faculty of Health, Sydney, New South Wales, Australia.

Alex Broom (A)

Faculty of Arts and Social Sciences, University of New South Wales, Sydney, New South Wales, Australia.

Jane Frawley (J)

Faculty of Public Health, University of Technology Sydney Faculty of Health, Sydney, New South Wales, Australia.

Jessica Bayes (J)

Faculty of Public Health, University of Technology Sydney Faculty of Health, Sydney, New South Wales, Australia jessica.bayes@yahoo.com.

Jon Adams (J)

Faculty of Public Health, University of Technology Sydney Faculty of Health, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH